jp morgan glp 1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPMorgan picks Perpetua Resources for

People today are becoming more aware of treatments that support healthier looking skin while helping protect the body against everyday oxidative stress

The reporting odds ratio and its advantages over the proportional reporting ratio

Tsang says using a GLP-1 requires practicing self-awareness and patience over time if you expect to lose weight and keep it off

Blood work should be checked to rule out thyroid dysfunction, iron deficiency, and other medical causes

Ongoing Commitment to Lifestyle The medication is a powerful tool, but it works best as part of a comprehensive program

Despite some promising findings, particularly in those with noise-induced tinnitus, gabapentins usefulness in tinnitus has not been clearly demonstrated